OMIC
OMIC Real Time Price USDRecent trades of OMIC by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by OMIC's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
OMIC Revenue by Segment or Geography
New patents grants
-
Patent Title: Multiomic analysis device and methods of use thereof Mar. 25, 2025
-
Patent Title: Multiomic analysis device and methods of use thereof Mar. 18, 2025
-
Patent Title: Microplate Mar. 18, 2025
-
Patent Title: Systems and methods for multicolor imaging Mar. 11, 2025
-
Patent Title: Microplate assembly Mar. 11, 2025
-
Patent Title: Microplate assembly Mar. 11, 2025
-
Patent Title: Compositions and methods for nucleic acid sequencing Feb. 18, 2025
-
Patent Title: Modified phi29 dna polymerases and uses thereof Feb. 18, 2025
-
Patent Title: Fluorinated nucleotides and uses thereof Feb. 04, 2025
-
Patent Title: Nucleotide analogues Feb. 04, 2025
-
Patent Title: Cleavable disulfide linkers and uses thereof Jan. 07, 2025
-
Patent Title: Multiplexed targeted amplification of polynucleotides Jan. 07, 2025
-
Patent Title: Device for tissue section immobilization and retention Dec. 31, 2024
-
Patent Title: Methods for in situ transcriptomics and proteomics Dec. 31, 2024
-
Patent Title: Flow cell receiver and methods of use Dec. 31, 2024
-
Patent Title: Manipulating and detecting biological samples Dec. 03, 2024
-
Patent Title: Nucleotide analogues Nov. 19, 2024
-
Patent Title: Methods of sequencing circular template polynucleotides Nov. 12, 2024
-
Patent Title: Polynucleotide barcodes for long read sequencing Nov. 12, 2024
-
Patent Title: Sample cartridge Nov. 05, 2024
-
Patent Title: Reagent cartridge Oct. 29, 2024
-
Patent Title: Linked paired strand sequencing Oct. 22, 2024
-
Patent Title: Methods for long read sequencing Oct. 22, 2024
-
Patent Title: Methods and compositions for reducing nucleotide impurities Oct. 15, 2024
-
Patent Title: Reagent cartridge Oct. 15, 2024
-
Patent Title: Methods of amplifying circular polynucleotides in situ Oct. 08, 2024
-
Patent Title: Modified Oct. 08, 2024
-
Patent Title: Kinematic imaging system Sep. 24, 2024
-
Patent Title: Linked paired strand sequencing Sep. 03, 2024
-
Patent Title: Nucleic acid circularization and amplification on a surface Aug. 27, 2024
-
Patent Title: Flow cell carrier device Aug. 20, 2024
-
Patent Title: Compositions and methods for nucleic acid sequencing Aug. 13, 2024
-
Patent Title: Reducing agents and uses thereof Aug. 06, 2024
-
Patent Title: Methods and compositions for reducing nucleotide impurities Jul. 09, 2024
-
Patent Title: Spatial sequencing Jun. 11, 2024
-
Patent Title: Silicon containing detectable compounds and uses thereof May. 21, 2024
-
Patent Title: Nucleotide cleavable linkers and uses thereof Apr. 30, 2024
-
Patent Title: Multiport disconnect couplings Apr. 23, 2024
-
Patent Title: Nucleotide analogues Apr. 16, 2024
-
Patent Title: Cleavable disulfide linkers and uses thereof Apr. 02, 2024
-
Patent Title: Amplification oligonucleotides Mar. 19, 2024
-
Patent Title: Methods and compositions for sequencing complementary polynucleotides Feb. 27, 2024
-
Patent Title: Imaging systems and methods useful for patterned structures Feb. 13, 2024
-
Patent Title: Linked paired strand sequencing Feb. 06, 2024
-
Patent Title: Methods for in situ transcriptomics and proteomics Feb. 06, 2024
-
Patent Title: Modified pyrococcus polymerases and uses thereof Feb. 06, 2024
-
Patent Title: Nanoarrays and methods of use thereof Jan. 30, 2024
-
Patent Title: Engineered Jan. 30, 2024
-
Patent Title: Microplate assembly Jan. 30, 2024
-
Patent Title: Microplate assembly Jan. 30, 2024
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to OMIC
Recent picks made for OMIC stock on CNBC
ETFs with the largest estimated holdings in OMIC
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $OMIC stock a Buy, Sell, or Hold?
- What is the price target for $OMIC stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $OMIC stock?
- Who owns the most shares of $OMIC stock?
- What funds own $OMIC stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view OMIC Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
No description available